Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr:90:23-27.
doi: 10.1016/j.clinbiochem.2021.01.004. Epub 2021 Jan 17.

Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers

Affiliations

Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers

Kristin E Mullins et al. Clin Biochem. 2021 Apr.

Abstract

Objectives: Serologic testing for SARS-CoV-2 is an important element in the fight to slow the COVID-19 pandemic. This study aimed to validate two serologic tests for total (IgM, IgG, IgA) SARS-CoV-2 antibodies, (i) the Ortho-Clinical Diagnostics Anti-SARS-CoV-2 Total Antibody assay for the Vitros 5600 analyzers and (ii) a manual laboratory developed ELISA (FDA EUA pending), for use in parallel orthogonal testing of asymptomatic healthcare workers and affiliates of the University of Maryland Medical System.

Design and methods: Validation and verification of the two tests was performed using samples from hospitalized patients that were found to be PCR positive for SARS-CoV-2, samples pre-COVID-19, and samples from individuals with current/previous infections with other viruses. Healthcare workers and affiliates from across the University of Maryland Health System were provided testing free of charge and their results were reported as reactive or non-reactive if the two tests were concordance, or indeterminate if the results were discordant.

Results: Validation testing found the Ortho Vitros test to be 100% (73/73) sensitive, and 99.3% (152/153) specific, while the UMMC ELISA was found to be 97.6% (204/209) sensitive and 100% (288/288) specific. Real world testing among 8399 healthcare workers found that 2.9% (247/8399) of healthcare workers were positive for anti- SARS-CoV-2 antibodies by both tests. An indeterminate rate of 1.1% (91/8399), in which one test reported reactive results, and one as non-reactive was also seen.

Conclusions: Parallel orthogonal testing improves the positive and negative predictive value of serologic testing in populations with low prevalence. The use of an indeterminate result from parallel orthogonal testing allows for the follow-up and re-testing, which helps resolve discrepancies between assays.

Keywords: COVID-19; SARS-CoV-2; Serology.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Lerner A.M., Eisinger R.W., Lowy D.R., Petersen L.R., Humes R., Hepburn M., Cassetti M.C. The COVID-19 Serology Studies Workshop: Recommendations and Challenges. Immunity. 2020;53(1):1–5. - PMC - PubMed
    1. The Food and Drug Administration. “EUA Authorized Serology Test Performance”. (2020) https://www.fda.gov/medical-devices/emergency-situations-medical-devices....
    1. Abbasi J. The Promise and Peril of Antibody Testing for COVID-19. JAMA. 2020;323(19):1881. doi: 10.1001/jama.2020.6170. - DOI - PubMed
    1. Rosenberg, Eli S., et al. “Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York.” medRxiv (2020). - PMC - PubMed
    1. Bendavid E. “COVID-19 Antibody Seroprevalence in Santa Clara County. California.“ MedRxiv. 2020 - PMC - PubMed

Publication types

MeSH terms